Merz Aesthetics
Merz Aesthetics is the medical-aesthetics business of the family-owned Merz Group and the principal commercial context for Radiesse. Radiesse entered the Merz portfolio through the 2010 acquisition of BioForm Medical. Current US regulatory and IFU records identify Merz North America in applicant and manufacturer roles.
Company reference
Section titled “Company reference”| Field | Merz Aesthetics |
|---|---|
| Core Injectable Index brand | Radiesse |
| Material relationship | CaHA |
| Parent context | Merz Group |
| Ownership | Family-owned and independent |
| Group headquarters | Frankfurt am Main, Germany |
| Relevant US entity | Merz North America, Inc. |
Merz describes itself as a global family-owned company, while Merz Aesthetics operates as its dedicated medical-aesthetics business (About Merz 🔗; Merz Aesthetics 🔗).
Product-role matrix
Section titled “Product-role matrix”| Product | Commercial portfolio | Product origin | Current US applicant | Manufacturer evidence |
|---|---|---|---|---|
| Radiesse | Merz Aesthetics | Entered Merz through BioForm Medical acquisition | Merz North America, Inc. in current FDA PMA records | Merz North America, Inc. in reviewed IFUs |
| Radiesse (+) | Merz Aesthetics | Same Radiesse franchise with lidocaine-containing presentation | Merz North America, Inc. | Merz North America, Inc. in reviewed IFUs |
This table is US-centered where it names applicant or manufacturer. Other markets can identify local importers, distributors, authorized representatives, or approval holders.
How Radiesse entered the portfolio
Section titled “How Radiesse entered the portfolio”Merz’s corporate history records the 2010 acquisition of BioForm Medical and its flagship product Radiesse (Merz history 🔗).
This history matters because older:
- studies
- regulator records
- IFUs
- safety reports
- corporate announcements
may use BioForm rather than Merz. A historical BioForm source is not necessarily outdated clinically, but the company relationship should be placed on a timeline.
Current regulatory roles
Section titled “Current regulatory roles”The FDA PMA database names Merz North America as applicant for current Radiesse supplements, including the March 31, 2026 décolleté indication expansion (FDA PMA history 🔗).
A reviewed Merz IFU identifies Merz North America as manufacturer of Radiesse (Merz IFU 🔗).
Use the exact regional IFU before extending these roles globally.
Portfolio context
Section titled “Portfolio context”Merz Aesthetics’ broader portfolio includes injectables, devices, and skincare. For the Collagen Stimulators cluster, Radiesse is the relevant anchor.
Other Merz products should appear only when they clarify:
- combination portfolio structure
- company identity
- a specific comparison
- regulatory or commercial relationships
Do not add unrelated Merz products merely to make the company page appear comprehensive.
Selective timeline
Section titled “Selective timeline”| Date | Event | Why it changes interpretation |
|---|---|---|
| 1908 | Merz founded in Frankfurt | Establishes family-company origin |
| 2010 | Merz acquired BioForm Medical and Radiesse | Explains the transition from legacy BioForm sources to Merz ownership |
| 2020 | Merz established independently operating Aesthetics, Therapeutics, and Consumer Care businesses | Clarifies the present business-unit structure |
| March 31, 2026 | FDA expanded Radiesse indication to 1:2 diluted décolleté use | Adds a current product-specific US regulatory milestone |
Company-page boundaries
Section titled “Company-page boundaries”Do not use Merz Aesthetics’ portfolio position to infer:
- that every CaHA product is Radiesse
- one universal Radiesse indication
- that Radiesse (+) and Radiesse are identical
- that diluted CaHA techniques are approved across all anatomies
- that family ownership changes product-level evidence
Related pages
Section titled “Related pages”- Regional regulation separates Merz’s US applicant role from European conformity and Korean intended-use evidence.
- Radiesse contains formulation, variant, dilution, and FDA-indication detail.
- CaHA explains the microsphere and carrier distinction.
- Sinclair provides a company comparison with multiple collagen-stimulator materials.
- Collagen Stimulators maps the wider company graph.